An Expert Perspective on Phosphate Dysregulation With a Focus on Chronic Hypophosphatemia

dc.contributor.authorAljuraibah, Fahad
dc.contributor.authorBacchetta, Justine
dc.contributor.authorBrandi, Maria Luisa
dc.contributor.authorFlorenzano, Pablo
dc.contributor.authorJavaid, Muhammad K.
dc.contributor.authorMakitie, Outimaija
dc.contributor.authorRaimann, Adalbert
dc.contributor.authorRodriguez, Mariano
dc.contributor.authorSiggelkow, Heide
dc.contributor.authorTiosano, Dov
dc.contributor.authorVervloet, Marc
dc.contributor.authorWagner, Carsten A.
dc.contributor.authoraffiliation[Aljuraibah, Fahad] King Saud Bin Abdulaziz Univ Hlth Sci, Coll Med, Riyadh, Saudi Arabia
dc.contributor.authoraffiliation[Bacchetta, Justine] Hop Femme Mere Enfant, INSERM1033 Res Unit, Bron, France
dc.contributor.authoraffiliation[Brandi, Maria Luisa] Univ Florence, Florence, Italy
dc.contributor.authoraffiliation[Florenzano, Pablo] Pontificia Univ Catolica Chile, Santiago, Chile
dc.contributor.authoraffiliation[Javaid, Muhammad K.] Univ Oxford, Oxford, England
dc.contributor.authoraffiliation[Makitie, Outimaija] Univ Helsinki, Childrens Hosp, Helsinki, Finland
dc.contributor.authoraffiliation[Makitie, Outimaija] Helsinki Univ Hosp, Helsinki, Finland
dc.contributor.authoraffiliation[Raimann, Adalbert] Med Univ Vienna, Vienna, Austria
dc.contributor.authoraffiliation[Rodriguez, Mariano] Hosp Univ Reina Sofia, IMIBIC, Cordoba, Spain
dc.contributor.authoraffiliation[Siggelkow, Heide] Univ Med Ctr, Gottingen, Germany
dc.contributor.authoraffiliation[Tiosano, Dov] Rambam Med Ctr, Haifa, Israel
dc.contributor.authoraffiliation[Vervloet, Marc] Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
dc.contributor.authoraffiliation[Wagner, Carsten A.] Univ Zurich, Zurich, Switzerland
dc.contributor.authoraffiliation[Wagner, Carsten A.] Swiss Natl Ctr Competence Res NCCR Kidney CH, Zurich, Switzerland
dc.contributor.funderProjekt DEAL
dc.date.accessioned2025-01-07T13:24:29Z
dc.date.available2025-01-07T13:24:29Z
dc.date.issued2021-12-23
dc.description.abstractBecause of their rarity, diseases characterized by chronic hypophosphatemia can be underrecognized and suboptimally managed, resulting in poor clinical outcomes. Moreover, serum phosphate may not be measured routinely in primary care practice. Authors participated in several working sessions to advance the understanding of phosphate homeostasis and the causes, consequences, and clinical implications of chronic hypophosphatemia. Phosphate levels are regulated from birth to adulthood. Dysregulation of phosphate homeostasis can result in hypophosphatemia, which becomes chronic if phosphate levels cannot be normalized. Chronic hypophosphatemia may be underrecognized as serum phosphate measurement is not always part of routine analysis in the primary care setting and results might be misinterpreted, for instance, due to age-specific differences not being accounted for and circadian variations. Clinical consequences of chronic hypophosphatemia involve disordered endocrine regulation, affect multiple organ systems, and vary depending on patient age and the underlying disorder. Signs and symptoms of chronic hypophosphatemic diseases that manifest during childhood or adolescence persist into adulthood if the disease is inadequately managed, resulting in an accumulation of clinical deficits and a progressive, debilitating impact on quality of life. Early identification and diagnosis of patients with chronic hypophosphatemia is crucial, and clinical management should be started as soon as possible to maximize the likelihood of improving health outcomes. Furthermore, in the absence of a universally accepted description for "chronic hypophosphatemia," a definition is proposed here that aims to raise awareness of these diseases, facilitate diagnosis, and guide optimal phosphate management strategies by improving monitoring and assessment of patient response to treatment. (c) 2021 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).
dc.identifier.doi10.1002/jbmr.4486
dc.identifier.essn1523-4681
dc.identifier.issn0884-0431
dc.identifier.pmid34870347
dc.identifier.unpaywallURLhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jbmr.4486
dc.identifier.urihttps://hdl.handle.net/10668/25487
dc.identifier.wosID733646600001
dc.issue.number1
dc.journal.titleJournal of bone and mineral research
dc.journal.titleabbreviationJ. bone miner. res.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Reina Sofía
dc.organizationInstituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)
dc.page.number12-20
dc.publisherWiley
dc.rightsAttribution-NonCommercial 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.subjectPHOSPHATE HOMEOSTASIS
dc.subjectHYPOPHOSPHATEMIA
dc.subjectOSTEOMALACIA AND RICKETS
dc.subjectPARATHYROID HORMONE
dc.subjectVITAMIN D
dc.subjectFIBROBLAST GROWTH FACTOR 23
dc.subjectX-linked hypophosphatemia
dc.subjectSerum phosphorus
dc.subjectMetabolism
dc.subjectRickets
dc.subjectGrowth
dc.subjectAdults
dc.subjectAbnormalities
dc.subjectMechanisms
dc.subjectExperience
dc.subjectManagement
dc.titleAn Expert Perspective on Phosphate Dysregulation With a Focus on Chronic Hypophosphatemia
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number37
dc.wostypeArticle

Files